Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc.

Biotechnology Research

New York, NY 24,037 followers

Über uns

Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians.

Website
http://axsome.com
Industrie
Biotechnology Research
Größe des Unternehmens
201-500 Mitarbeiter
Hauptsitz
New York, NY
Typ
Öffentliches Unternehmen
Gegründet
2012
Spezialitäten
Biopharmaceuticals, Pain, CNS, Narcolepsy, Major Depressive Disorder, Alzheimer's Disease Agitation, Fibromyalgia, Smoking Cessation, Migraine, and Attention Deficit Hyperactivity Disorder

Standorte

Employees at Axsome Therapeutics, Inc.

Aktualisierungen

Ähnliche Seiten

Jobs durchsuchen

Finanzierung

Axsome Therapeutics, Inc. 6 total rounds

Letzte Runde

Eigenkapital nach dem IPO

US$ 225.0M

Siehe mehr Informationen auf crunchbase